“…As a surrogate for sDCs and NK cells abundance, expression of previously described signature genes of sDCs ( KIT , CCR7 , BATF3 , FLT3 (excluded from MCPcounter analysis), ZBTB46 , IRF8 , BTLA , MYCL1 ) and NK ( GNLY , KLRC3 , FLT3LG KLRD1 , KLRF1 , NCR1 ) has been adopted [ 9 , 26 , 27 ]. Spatial partitioning of LUSC and LUAD patients regarding their clinical characteristics was performed based on models of FLT3 ‐low/ FLT3 ‐high and T‐cell exhaustion marker gene expression ( PDCD1 (PD1), CD274 (PDL1), PDCD1LG2 (PDL2), CTLA4 , LAG3 , HAVCR2 (TIM3), GZMB , BTLA , CD160 , CD244 (2B4), TIGIT ) through the Multiple Factor Analysis (MFA) being an extension of the Principal Component Analysis (PCA) allowing to mix variables of different types [ 28 , 29 , 30 , 31 ].…”